0
Five Prime Therapeutics Inc Banner Image

Five Prime Therapeutics Inc

  • Ticker FPRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Five Prime Therapeutics Inc Logo Image
  • 51-200 Employees
  • Based in San Francisco, California
Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ib clinical trials for the treatment of rheumatoid arthritis; and in pre-INDMore stage for pigmented villonodular synovitis and multiple cancers in combination with nivolumab.
Five Prime Therapeutics Inc

Most Recent Annual Report

Five Prime Therapeutics Inc MOST RECENT 2019 Annual Report and Form 10K

Report Locked. Five Prime Therapeutics Inc has reached its limit for free report views.

Older/Archived Annual Reports